Page last updated: 2024-12-06

adamantylamide-alanyl-isoglutamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

adamantylamide-alanyl-isoglutamine: RN from Toxline [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID64548
SCHEMBL ID15531876
MeSH IDM0130830

Synonyms (8)

Synonym
(2r)-n'-(1-adamantyl)-2-(2-aminopropanoylamino)pentanediamide
d-glutamamide, l-alanyl-n5-tricyclo(3.3.1.1(3,7))dec-1-yl-
89813-21-8
l-alanyl-n5-tricyclo(3.3.1.1(3,7))dec-1-yl-d-glutamamide
adamantylamide-alanyl-isoglutamine
SCHEMBL15531876
DTXSID101008985
n~5~-(adamantan-1-yl)-2-[(2-amino-1-hydroxypropylidene)amino]pentanediimidic acid

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"A pharmacokinetic profile of 14C-AdDP with uniformly labelled alanine was investigated."( Pharmacokinetic profile of the immunomodulating compound adamantylamide dipeptide (AdDP), a muramyl dipeptide derivative in mice.
Buchar, E; Flegel, M; Janků, I; Machková, Z; Masek, K; Vrba, T; Walder, P, 1991
)
0.28

Dosage Studied

ExcerptRelevanceReference
" A clear adjuvant dose-response relationship was observed on the increment of Ova-specific serum antibody titers when AdDP was used as adjuvant, irrespectively of the administration route."( Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice.
Becker, PD; Corral, RS; Grinstein, S; Guzmán, CA, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (23.08)18.7374
1990's10 (38.46)18.2507
2000's10 (38.46)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.08 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (7.41%)5.53%
Reviews2 (7.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (85.19%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]